Triptolide C-ring derivatives as anticancer agents and immune modulators

Details for Australian Patent Application No. 2010210594 (hide)

Owner Pharmagenesis, Inc.

Inventors Musser, John H.

Agent FB Rice

Pub. Number AU-A-2010210594

PCT Pub. Number WO2010/091193

Priority 61/150,207 05.02.09 US

Filing date 4 February 2010

Wipo publication date 12 August 2010

International Classifications

C07D 493/04 (2006.01) Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61P 35/00 (2006.01) Antineoplastic agents

C07D 307/88 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

Event Publications

18 August 2011 PCT application entered the National Phase

  PCT publication WO2010/091193 Priority application(s): WO2010/091193

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010210598-Tablets for combination therapy

2010210593-Nanoscale platinum compounds and methods of use thereof